Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 28 (1) , 143-154
Abstract
Glucose-6-phosphatase α (G6Pase) deficiency, also known as von Gierke’s Disease or Glycogen storage disease type Ia (GSD Ia), is characterized by decreased ability of the liver to convert glucose-6-phosphate to glucose leading to glycogen accumulation and hepatosteatosis. Long-term complications of GSD Ia include hepatic adenomas and carcinomas, in association with the suppression of autophagy in the liver. The G6pc−/− mouse and canine models for GSD Ia were treated with the pan-peroxisomal proliferator-activated receptor agonist, bezafibrate, to determine the drug’s effect on liver metabolism and function. Hepatic glycogen and triglyceride concentrations were measured and western blotting was performed to investigate pathways affected by the treatment. Bezafibrate decreased liver triglyceride and glycogen concentrations and partially reversed the autophagy defect previously demonstrated in GSD Ia models. Changes in medium-chain acyl-CoA dehydrogenase expression and acylcarnintine flux suggested that fatty acid oxidation was increased and fatty acid synthase expression associated with lipogenesis was decreased in G6pc−/− mice treated with bezafibrate. In summary, bezafibrate induced autophagy in the liver while increasing fatty acid oxidation and decreasing lipogenesis in G6pc−/− mice. It represents a potential therapy for glycogen overload and hepatosteatosis associated with GSD Ia, with beneficial effects that have implications for non-alcoholic fatty liver disease.Keywords
Funding Information
- National Medical Research Council (NMRC/CIRG/1340/2012, NRMC/CSA/0054/2013, NMRC/BING/2025/2014)
- National Institute of Diabetes and Digestive and Kidney Diseases (grant 5R01DK105434-04)
- Roivant Rare Diseases, and by the Alice
- Chen Center for Genetics and Genomics
This publication has 54 references indexed in Scilit:
- Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosisClinical and Molecular Hepatology, 2013
- Alpha-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cellsEuropean Journal of Pharmacology, 2012
- Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagyJournal of Clinical Investigation, 2012
- Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and FeedbacksMolecular and Cellular Biology, 2012
- Mechanisms of Autophagosome BiogenesisCurrent Biology, 2012
- Autophagy, mitochondria and oxidative stress: cross-talk and redox signallingBiochemical Journal, 2011
- Glucose-6-phosphatase deficiencyOrphanet Journal of Rare Diseases, 2011
- Autophagy: assays and artifactsThe Journal of Pathology, 2010
- Autophagy regulates lipid metabolismNature, 2009
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000